Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
66,587,586
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
1,358,062
-
Shares change
-
+8,748
-
Total reported value, excl. options
-
$5,732,000
-
Value change
-
+$37,042
-
Number of buys
-
3
-
Number of sells
-
-5
-
Price
-
$4.22
Significant Holders of Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) as of Q3 2022
16 filings reported holding ARMP - Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value as of Q3 2022.
Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,358,062 shares
of 66,587,586 outstanding shares and own 2.04% of the company stock.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (633,944 shares), VANGUARD GROUP INC (287,350 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (113,682 shares), EDGEWOOD MANAGEMENT LLC (100,000 shares), RENAISSANCE TECHNOLOGIES LLC (69,796 shares), SYNOVUS FINANCIAL CORP (47,903 shares), BlackRock Inc. (24,008 shares), GEODE CAPITAL MANAGEMENT, LLC (22,528 shares), NORTHERN TRUST CORP (19,380 shares), and SeaCrest Wealth Management, LLC (17,550 shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.